MAIA Biotechnology, Inc. 8-K

What Happened
MAIA Biotechnology, Inc. announced in a Form 8-K that its Board approved one-time bonus payments related to the company’s recent capital raise. On March 27, 2026 the Board approved a $312,610 bonus for Chief Executive Officer Vlad Vitoc and a $50,000 bonus for Head of Finance Jeffrey Himmelreich. The bonuses were paid on March 31, 2026.

Key Details

• Board approval date: March 27, 2026.
• Payment date: March 31, 2026.
• Amounts: $312,610 to CEO Vlad Vitoc; $50,000 to Head of Finance Jeffrey Himmelreich (total $362,610).
• Reason cited: Compensation for efforts in connection with the company’s recent capital raise.

Why It Matters
These one-time payments affect executive compensation and reflect actions tied to the company’s capital-raising activities. For investors, the filing signals management was materially involved in securing financing and that the company authorized discretionary payouts for that work. The 8-K also includes the company’s standard forward-looking statement caution.